v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income (loss) $ (5,465) $ 956
Adjustments to reconcile net income (loss) to net cash and cash equivalents and net restricted cash and cash equivalents provided by operating activities:    
Change in fair value of financial instruments 162 (1,221)
Inventory write-down for excess & obsolescence 192 178
Loss on contingent liability 58 25
Stock-based compensation 15 70
Depreciation 4 6
Amortization of intangible asset 75 223
Noncash interest expense 614 577
Noncash right-of-use asset amortization 32 37
Net loss on disposal or impairment of property and equipment 17
Gain on accounts payable and accrued expenses settlements (5,607)
Changes in operating assets and liabilities:    
Trade accounts receivable 11,920 8,683
Inventories (761) (864)
Prepaid and other assets (130) 107
Accounts payable (1,605) (1,776)
Accrued expenses and other liabilities (1,636) 34
Accrued compensation (1,092) (849)
Contingent liabilities (50)
Operating lease liabilities (32) (36)
Net cash and cash equivalents and net restricted cash and cash equivalents provided by operating activities 2,301 560
Cash flows from investing activities:    
Payments related to intangible asset acquisition (57)
Purchases of property and equipment (2)
Net cash and cash equivalents and net restricted cash and cash equivalents used in investing activities (2) (57)
Cash flows from financing activities:    
Payments under short term debt and Notes – carried at fair value (498) (135)
Net cash and cash equivalents and net restricted cash and cash equivalents used in financing activities (498) (135)
Net change in cash and cash equivalents and net restricted cash and cash equivalents 1,801 368
Cash and cash equivalents and restricted cash and cash equivalents beginning of period 578 741
Cash, cash equivalents and restricted cash and cash equivalents end of period 2,379 1,109
Supplemental disclosure of noncash investing and financing activities:    
Net decrease in contingent liabilities 3,495 2,887
Series E-1 Shares and Series G-1 Shares deemed dividends 20 3
Issuance of Common Stock upon conversion of Series G-1 Shares $ 1